Dr. Timothy Miller is the first director of the Christopher Wells Hobler Laboratory for ALS Research, where he investigates methods to turn off harmful genes in the brain and spinal cord. These novel therapeutic strategies will be applied to patients with neurodegenerative diseases, in particular ALS and Alzheimer’s disease.
Dr. Miller’s current research examines techniques to determine how quickly these novel therapies will affect patients. Successful completion of these studies will yield better, faster ways to assess the effectiveness of future therapies in humans.
View the latest news articles featuring the Miller Lab’s research, such as the video below.
Dr. Miller is featured in this 2011 informational video from the Muscular Dystrophy Association about antisense oligonucleotides and their use in treating ALS.